BCX4208
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BCX4208, covering 2012-01-23 to 2012-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout [Phase 2]